{"disease":{"id":"hepatitis-c-human-immunodeficiency-virus-coinfection","name":"hepatitis c human immunodeficiency virus coinfection"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04768517","title":"HCV Reinfection in in HIV/HCV-coinfected Patients Achieving SVR by Antiviral Therapy","phase":"","overall_status":"UNKNOWN","enrollment_count":300,"lead_sponsor_name":"National Taiwan University Hospital","has_results":false},{"nct_id":"NCT02103439","title":"An Open-label Randomized Multicenter Phase III Clinical Study Comparing Safety and Efficacy of Algeron (Cepeginterferon Alfa-2b) and and PegIntron (Peginterferon Alfa-2b) in Combination With Ribavirin as Combined Treatment of Chronic Hepatitis C in Human Immunodeficiency Virus-1 Infected Patients","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":140,"lead_sponsor_name":"Biocad","has_results":true}],"total":2},"guidelines":[],"source":"Drug Landscape verified database"}